Learn how the FIDELITY risk model helps clinicians predict hyperkalaemia in CKD and diabetes-read on for clinical insights.

This article sheds light on Type 2 diabetes, and the importance of holistic management and culturally competent care.​ ...

Diuretic use does not affect safety and efficacy outcomes in patients with type 2 diabetes and chronic kidney disease receiving finerenone.

The study published in the Lancet on April 30 was the outcome of research, which was funded in part by the China's government ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

As mentioned previously, damaged blood vessels can lead to kidney damage, but there are also other issues that smoking causes ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i), or gliflozins, are medications used in the treatment of type 2 diabetes ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

The latest findings provide reassurance for nephrologists who may be hesitant to prescribe these types of medications.

Diabetic kidney disease is chronic kidney disease that occurs as a complication of diabetes. Learn about its signs and ...

SGLT2 inhibitors were most effective for reducing HbA1c, blood pressure, and body weight, with canagliflozin showing the lowest adverse event likelihood. GLP-1 receptor agonists, particularly ...

The following is a summary of “Comparison of artificial intelligence-generated and physician-generated patient education ...